1. Home
  2. |Insights
  3. |Fourth Webinar of “Exploring the U.S. Market Webinar Series”: Regulating the Use of Artificial Intelligence - An Early Exploration of the EU and USA Legislative Initiatives

Fourth Webinar of “Exploring the U.S. Market Webinar Series”: Regulating the Use of Artificial Intelligence - An Early Exploration of the EU and USA Legislative Initiatives

Webinar | 02.22.24, 4:00 PM CET - 5:30 AM CET

Address

Virtual

In Collaboration with IBJ

There are business opportunities abound in and with the U.S. You just have to know where to find them and how to navigate through the rules and regulations. Crowell presents the fourth in a series of webinars in which we will help you to successfully do business in and with the U.S.

The exciting developments in artificial intelligence technology have led to new business opportunities for companies around the globe. New companies are popping up every day that offer services that rely on AI technology and established companies enhance their offering with AI features. But AI has not just caught the interest of the private sector: governments worldwide are turning their attention towards AI.

In the fourth installment of the series, our speakers will cover the legal and regulatory landscape surrounding the use of AI technology. This landscape spans from the AI Act in the EU to the complex legal framework in the US, where the executive, legislative, and judicial branches of the federal and state governments are having their say.

In short, this presentation will provide valuable insights for any company interested in offering or using AI-based product or services in the EU and in the U.S.

Questions - For questions about this webinar, please contact Danica Schiefer.

For more information, please visit these areas: Brussels Practice, Artificial Intelligence, Artificial Intelligence

Insights

Webinar | 10.28.26

AI Governance & Vendor Diligence for Providers

Health care providers are deploying AI at an unprecedented pace—from ambient documentation and AI-assisted diagnostics to remote patient monitoring—but rapid adoption brings significant legal, regulatory, and reputational risk. A growing patchwork of state AI laws, evolving federal frameworks, and emerging litigation are reshaping what providers must do to deploy these tools responsibly.